Amgen Pharma Fintech (Hong Kong) Limited
睿莱环球有限公司
Amgen Pharma Fintech (Hong Kong) Limited (睿萊環球有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622). Its Business Registration Number (BRN) is 78589963, classified as a Private company limited by shares. Incorporated on 2025-08-06, the entity has maintained continuous statutory operations for 1 year, currently holding an active legal status of Live. The registered office is situated at FLAT 2401-16, 24/F,, WING SHING INDUSTRIAL BUILDING,, 26 NG FONG STREET,, SAN PO KONG, HONG KONG. You may search and order official filing extracts (NAR1/NNC1/ND2A) or request a full commercial due diligence report for Ultimate Beneficial Owner (UBO) penetration.
I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 睿萊環球有限公司 | Official English Name | Amgen Pharma Fintech (Hong Kong) Limited |
|---|---|---|---|
| Business Reg No. (BRN) | 78589963 | Company Reg No. (CR) | — (No CR Registered) |
| Company Category | Private company limited by shares | Incorporation Date | 2025-08-06 |
| Current Legal Status | Live | Statutory Filing Cycle | 2026-08-06 |
| Registered Office Address |
FLAT 2401-16, 24/F,, WING SHING INDUSTRIAL BUILDING,, 26 NG FONG STREET,, SAN PO KONG, HONG KONG
|
||
| Significant Controllers (SCR) | Pursuant to Part 12 Division 2A of Cap. 622, SCR records are kept at the registered office. Order our Due Diligence Report to penetrate UBO controllers. | ||
II. Companies Registry Statutory Image Records
Click below to connect with our compliance specialist. The system will immediately query the official Companies Registry database to render the complete archived filing list for this entity.
| Item | Filing Date | Form Ref. | Document Name | Pages | Format | Fee | Action |
|---|---|---|---|---|---|---|---|
| 1 | 2026-08-06 | NAR1 |
NAR1 Statutory Filing
|
17 | ¥28.00 | ||
| 2 | 2025-08-15 | ND2A |
ND2A Statutory Filing
|
4 | ¥28.00 | ||
| 3 | 2025-08-06 | A&A |
A&A Statutory Filing
|
32 | ¥28.00 | ||
| 4 | 2025-08-06 | NNC1 |
NNC1 Statutory Filing
|
22 | ¥28.00 | ||
| 5 | 2025-08-06 | NAR1 |
NAR1 Statutory Filing
|
16 | ¥28.00 |
III. Commercial Due Diligence & Regulatory Risk Screening
Our compliance specialists assist with deep corporate penetration, offshore UBO shareholding structures, court litigation dockets, and global sanctions screening.
IV. Similar Trade Names & Industry Directory
Aurora Interactive Limited
香港极光互动有限公司
HXIAN TRADING LIMITED
豪祥贸易有限公司
JIALE PLASTIC HARDWARE PR…
嘉乐塑料五金制品有限公司
RICHARDS COMPANY LIMITED
滙策事务所有限公司
Pure Supplies Trading Com…
純净用品贸易有限公司